(2S,4R)-1-[(2S)-2-acetamido-3,3-dimethylbutanoyl]-N-[(1S)-1-(4-cyclopropylphenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide is a highly selective ligand for the von Hippel-Lindau (VHL) E3 ligase, serving as a key component in PROTAC (Proteolysis Targeting Chimera) drug development. Classified as an E3 Ligase Ligand, this compound enables targeted protein degradation by facilitating the recruitment of target proteins to the ubiquitin-proteasome system. It is widely utilized in the synthesis of VHL-based PROTACs, allowing researchers to explore new modalities in drug discovery and the selective knockdown of pathogenic proteins.
Structure of 2320561-69-9
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(2S,4R)-1-[(2S)-2-acetamido-3,3-dimethylbutanoyl]-N-[(1S)-1-(4-cyclopropylphenyl)ethyl]-4-hydroxypyrrolidine-2-carboxamide is a synthetic ligand specifically designed for the recruitment of the Von Hippel-Lindau (VHL) E3 ubiquitin ligase, a core component frequently utilized in PROTAC (Proteolysis Targeting Chimeras) technology. VHL-based ligands are widely recognized for their efficiency in targeted protein degradation (TPD) and have become foundational in the next-generation drug discovery platforms.
Mechanism
This VHL ligand selectively binds to the VHL E3 ubiquitin ligase complex, facilitating the recruitment of VHL to a protein of interest when linked via a suitable linker to a specific target ligand. The resulting bifunctional PROTAC molecule bridges the E3 ligase and the target protein, instigating ubiquitination and subsequent proteasomal degradation of the target. The compound's pyrrolidine core and optimized side chains ensure high affinity and specificity for the VHL complex, making it an effective tool for designing potent PROTACs.
Applications
This VHL ligand plays a vital role in the synthesis and optimization of PROTACs for targeted protein degradation. Key applications include:
• Design and construction of VHL-recruiting PROTACs in drug discovery, especially for 'undruggable' targetsDue to its robust binding and modular linker compatibility, this ligand is an essential building block in the growing field of targeted protein degradation.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.